Island Pharmaceuticals Limited (ILA.AX)
AUD 0.19
(11.76%)
AUD 0.19
(11.76%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 4.12 Million AUD | 41.86% |
| 2023 | 2.9 Million AUD | 3.53% |
| 2022 | 2.8 Million AUD | 31.33% |
| 2021 | 2.13 Million AUD | 324967.33% |
| 2020 | 658.00 AUD | -99.85% |
| 2019 | 430 Thousand AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 FY | 4.12 Million AUD | 41.86% |
| 2024 Q4 | 996.9 Thousand AUD | 0.0% |
| 2024 Q2 | 2.13 Million AUD | 423.57% |
| 2024 Q3 | 996.9 Thousand AUD | -53.23% |
| 2024 Q1 | 407.12 Thousand AUD | -67.96% |
| 2023 Q2 | 1.63 Million AUD | 249.82% |
| 2023 Q1 | 468.05 Thousand AUD | -75.03% |
| 2023 FY | 2.9 Million AUD | 3.53% |
| 2023 Q4 | 1.27 Million AUD | 107.28% |
| 2023 Q3 | 613.08 Thousand AUD | -62.56% |
| 2022 Q3 | 880.43 Thousand AUD | -5.82% |
| 2022 Q4 | 1.87 Million AUD | 112.87% |
| 2022 FY | 2.8 Million AUD | 31.33% |
| 2022 Q2 | 934.82 Thousand AUD | 120.99% |
| 2022 Q1 | 423.01 Thousand AUD | -80.22% |
| 2021 Q1 | 41.00 AUD | 0.0% |
| 2021 FY | 2.13 Million AUD | 324967.33% |
| 2021 Q4 | 2.13 Million AUD | 101.15% |
| 2021 Q3 | 1.06 Million AUD | 2593402.44% |
| 2021 Q2 | 41.00 AUD | 0.0% |
| 2020 FY | 658.00 AUD | -99.85% |
| 2019 FY | 430 Thousand AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AdAlta Limited | 6.76 Million AUD | 39.06% |
| Acrux Limited | 8.55 Million AUD | 51.75% |
| Actinogen Medical Limited | 22.77 Million AUD | 81.883% |
| AnteoTech Limited | 12.18 Million AUD | 66.15% |
| Argenica Therapeutics Limited | 8.26 Million AUD | 50.111% |
| Arovella Therapeutics Limited | 10.78 Million AUD | 61.75% |
| Anatara Lifesciences Ltd | 710.21 Thousand AUD | -480.859% |
| Alterity Therapeutics Limited | 23.4 Million AUD | 82.375% |
| Amplia Therapeutics Limited | 8.43 Million AUD | 51.097% |
| Avecho Biotechnology Limited | 4.54 Million AUD | 9.241% |
| Bio-Gene Technology Limited | 2.76 Million AUD | -49.415% |
| Biome Australia Limited | 7.91 Million AUD | 47.854% |
| Biotron Limited | 5.11 Million AUD | 19.28% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | -585.48% |
| BTC Health Limited | -1.03 Million AUD | 497.079% |
| Chimeric Therapeutics Limited | 19.76 Million AUD | 79.13% |
| CSL Limited | 7.56 Billion AUD | 99.945% |
| Clarity Pharmaceuticals Ltd | 56.3 Million AUD | 92.673% |
| Clinuvel Pharmaceuticals Limited | 31.29 Million AUD | 86.819% |
| Cynata Therapeutics Limited | 11.12 Million AUD | 62.913% |
| Dimerix Limited | 25.64 Million AUD | 83.913% |
| EZZ Life Science Holdings Limited | 39.57 Million AUD | 89.576% |
| Hexima Limited | 1 Million AUD | -308.957% |
| Immuron Limited | 9.13 Million AUD | 54.855% |
| Immutep Limited | 42.87 Million AUD | 90.378% |
| Imugene Limited | 135.09 Million AUD | 96.946% |
| Invex Therapeutics Ltd | 3.34 Million AUD | -23.296% |
| Memphasys Limited | 3.67 Million AUD | -12.151% |
| Nanollose Limited | 12.5 Thousand AUD | -32900.208% |
| Neuren Pharmaceuticals Limited | 32.69 Million AUD | 87.383% |
| Noxopharm Limited | 7 Million AUD | 41.068% |
| NeuroScientific Biopharmaceuticals Limited | 1.96 Million AUD | -109.918% |
| Nyrada Inc. | 4.55 Million AUD | 9.436% |
| Orthocell Limited | 15.36 Million AUD | 73.159% |
| PharmAust Limited | 6.65 Million AUD | 38.03% |
| Patrys Limited | 4.93 Million AUD | 16.378% |
| Paradigm Biopharmaceuticals Limited | 65.1 Million AUD | 93.663% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | -362.41% |
| Prescient Therapeutics Limited | 10.89 Million AUD | 62.148% |
| PYC Therapeutics Limited | 60.91 Million AUD | 93.228% |
| Race Oncology Limited | 14.77 Million AUD | 72.07% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | -1278.666% |
| Recce Pharmaceuticals Ltd | 21.68 Million AUD | 80.976% |
| Starpharma Holdings Limited | 22.81 Million AUD | 81.919% |
| Telix Pharmaceuticals Limited | 269.26 Million AUD | 98.468% |
| Tissue Repair Ltd | 6.66 Million AUD | 38.121% |
| Zelira Therapeutics Limited | 5.94 Million AUD | 30.649% |